BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12702726)

  • 1. Specific interaction of protein tyrosine phosphatase-MEG2 with phosphatidylserine.
    Zhao R; Fu X; Li Q; Krantz SB; Zhao ZJ
    J Biol Chem; 2003 Jun; 278(25):22609-14. PubMed ID: 12702726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of protein tyrosine phosphatase PTP-MEG2.
    Qi Y; Zhao R; Cao H; Sui X; Krantz SB; Zhao ZJ
    J Cell Biochem; 2002; 86(1):79-89. PubMed ID: 12112018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homotypic secretory vesicle fusion induced by the protein tyrosine phosphatase MEG2 depends on polyphosphoinositides in T cells.
    Huynh H; Wang X; Li W; Bottini N; Williams S; Nika K; Ishihara H; Godzik A; Mustelin T
    J Immunol; 2003 Dec; 171(12):6661-71. PubMed ID: 14662869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells.
    Xu MJ; Sui X; Zhao R; Dai C; Krantz SB; Zhao ZJ
    Blood; 2003 Dec; 102(13):4354-60. PubMed ID: 12920026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling.
    Cho CY; Koo SH; Wang Y; Callaway S; Hedrick S; Mak PA; Orth AP; Peters EC; Saez E; Montminy M; Schultz PG; Chanda SK
    Cell Metab; 2006 May; 3(5):367-78. PubMed ID: 16679294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of vesicle fusion by a tyrosine phosphatase.
    Huynh H; Bottini N; Williams S; Cherepanov V; Musumeci L; Saito K; Bruckner S; Vachon E; Wang X; Kruger J; Chow CW; Pellecchia M; Monosov E; Greer PA; Trimble W; Downey GP; Mustelin T
    Nat Cell Biol; 2004 Sep; 6(9):831-9. PubMed ID: 15322554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTP-MEG2 regulates quantal size and fusion pore opening through two distinct structural bases and substrates.
    Xu YF; Chen X; Yang Z; Xiao P; Liu CH; Li KS; Yang XZ; Wang YJ; Zhu ZL; Xu ZG; Zhang S; Wang C; Song YC; Zhao WD; Wang CH; Ji ZL; Zhang ZY; Cui M; Sun JP; Yu X
    EMBO Rep; 2021 May; 22(5):e52141. PubMed ID: 33764618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening, optimization, and identification of a novel specific PTP-MEG2 Inhibitor with potential therapy for T2DM.
    Wang M; Li X; Dong L; Chen X; Xu W; Wang R
    Oncotarget; 2016 Aug; 7(32):50828-50834. PubMed ID: 27384997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphatase PTP-MEG2 negatively regulates vascular endothelial growth factor receptor signaling and function in endothelial cells.
    Hao Q; Samten B; Ji HL; Zhao ZJ; Tang H
    Am J Physiol Cell Physiol; 2012 Sep; 303(5):C548-53. PubMed ID: 22763125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Protein Tyrosine Phosphatase MEG2 Regulates the Transport and Signal Transduction of Tropomyosin Receptor Kinase A.
    Zhang D; Marlin MC; Liang Z; Ahmad M; Ashpole NM; Sonntag WE; Zhao ZJ; Li G
    J Biol Chem; 2016 Nov; 291(46):23895-23905. PubMed ID: 27655914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phloridzin Acts as an Inhibitor of Protein-Tyrosine Phosphatase MEG2 Relevant to Insulin Resistance.
    Yoon SY; Yu JS; Hwang JY; So HM; Seo SO; Kim JK; Jang TS; Chung SJ; Kim KH
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-tyrosine phosphatase MEG2 is expressed by human neutrophils. Localization to the phagosome and activation by polyphosphoinositides.
    Kruger JM; Fukushima T; Cherepanov V; Borregaard N; Loeve C; Shek C; Sharma K; Tanswell AK; Chow CW; Downey GP
    J Biol Chem; 2002 Jan; 277(4):2620-8. PubMed ID: 11711529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enlargement of secretory vesicles by protein tyrosine phosphatase PTP-MEG2 in rat basophilic leukemia mast cells and Jurkat T cells.
    Wang X; Huynh H; Gjörloff-Wingren A; Monosov E; Stridsberg M; Fukuda M; Mustelin T
    J Immunol; 2002 May; 168(9):4612-9. PubMed ID: 11971009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of protein-tyrosine phosphatase MEG2 via its Sec14p homology domain with vesicle-trafficking proteins.
    Saito K; Williams S; Bulankina A; Höning S; Mustelin T
    J Biol Chem; 2007 May; 282(20):15170-8. PubMed ID: 17387180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine phosphatase-1B dephosphorylation of the insulin receptor occurs in a perinuclear endosome compartment in human embryonic kidney 293 cells.
    Romsicki Y; Reece M; Gauthier JY; Asante-Appiah E; Kennedy BP
    J Biol Chem; 2004 Mar; 279(13):12868-75. PubMed ID: 14722096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, biological evaluation and molecular dynamics simulation studies of (R)-5-methylthiazolidin-4-One derivatives as megakaryocyte protein tyrosine phosphatase 2 (PTP-MEG2) inhibitors for the treatment of type 2 diabetes.
    Wu J; Sun Y; Zhou H; Ma Y; Wang R
    J Biomol Struct Dyn; 2020 Jul; 38(11):3156-3165. PubMed ID: 31402760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, bioactivity, 3D-QSAR studies of novel dibenzofuran derivatives as PTP-MEG2 inhibitors.
    Ma Y; Wei HY; Zhang YZ; Jin WY; Li HL; Zhou H; Cheng XC; Wang RL
    Oncotarget; 2017 Jun; 8(24):38466-38481. PubMed ID: 28388567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and expression of a cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to retinaldehyde-binding protein and yeast SEC14p.
    Gu M; Warshawsky I; Majerus PW
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2980-4. PubMed ID: 1557404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane targeting of protein tyrosine phosphatase PTPL1 through its FERM domain via binding to phosphatidylinositol 4,5-biphosphate.
    Bompard G; Martin M; Roy C; Vignon F; Freiss G
    J Cell Sci; 2003 Jun; 116(Pt 12):2519-30. PubMed ID: 12766187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphatase MEG2 modulates murine development and platelet and lymphocyte activation through secretory vesicle function.
    Wang Y; Vachon E; Zhang J; Cherepanov V; Kruger J; Li J; Saito K; Shannon P; Bottini N; Huynh H; Ni H; Yang H; McKerlie C; Quaggin S; Zhao ZJ; Marsden PA; Mustelin T; Siminovitch KA; Downey GP
    J Exp Med; 2005 Dec; 202(11):1587-97. PubMed ID: 16330817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.